Stockscreener 앱 받기
1.96
1.51%
-0.03
시간 외 거래:
1.92
-0.04
-2.04%
전일 마감가:
$1.99
열려 있는:
$1.99
하루 거래량:
154.63K
Relative Volume:
0.63
시가총액:
$7.05M
수익:
-
순이익/손실:
$-15.47M
주가수익비율:
-3.92
EPS:
-0.5
순현금흐름:
$-13.51M
1주 성능:
-7.55%
1개월 성능:
+3.16%
6개월 성능:
+27.27%
1년 성능:
-65.52%
1일 변동 폭
$1.90
$2.02
1주일 범위
$1.88
$2.1358
52주 변동 폭
$1.30
$6.972
Nls Pharmaceutics Ltd Stock (NLSP) Company Profile
NLSP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NLSP
Nls Pharmaceutics Ltd
|
1.96 | 9.77M | 0 | -15.47M | -13.51M | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Nls Pharmaceutics Ltd 주식(NLSP)의 최신 뉴스
Earnings visualization tools for NLS Pharmaceutics AG2025 Top Gainers & Fast Entry Momentum Alerts - Newser
Will earnings trigger a reversal in NLS Pharmaceutics AG Equity WarrantWeekly Market Outlook & Accurate Technical Buy Alerts - Newser
What’s the recovery path for long term holders of NLS Pharmaceutics AG Equity WarrantEarnings Miss & Long-Term Growth Stock Strategies - Newser
Using RSI to spot recovery in NLS Pharmaceutics AGWeekly Trend Report & Verified Short-Term Trading Plans - Newser
Using Bollinger Bands to evaluate NLS Pharmaceutics AGJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - Newser
Key metrics from NLS Pharmaceutics AG Equity Warrant’s quarterly dataExit Point & Fast Exit and Entry Trade Guides - Newser
Top chart patterns to watch in NLS Pharmaceutics AG Equity WarrantAnalyst Upgrade & Capital Efficient Trading Techniques - Newser
NLS Pharmaceutics and Kadimastem Secure Hong Kong Patent for Diabetes Therapy - TipRanks
NLS Pharmaceutics and Kadimastem announce a Hong Kong Patent Covering Cell-Selection and Enrichment Technology for IsletRx for Diabetes Patients - PR Newswire
Using Bollinger Bands to evaluate NLS Pharmaceutics AG Equity WarrantMarket Activity Report & Low Risk Entry Point Guides - Newser
Statistical indicators supporting NLS Pharmaceutics AG Equity Warrant’s strength2025 Market Sentiment & Real-Time Stock Price Movement Reports - Newser
Predicting NLS Pharmaceutics AG Equity Warrant trend using moving averagesQuarterly Profit Review & Free Expert Approved Momentum Trade Ideas - Newser
Analyzing drawdowns of NLS Pharmaceutics AG Equity Warrant with statistical toolsM&A Rumor & AI Forecasted Stock Moves - Newser
Can NLS Pharmaceutics AG stock double in the next yearJuly 2025 Institutional & Stepwise Trade Execution Plans - خودرو بانک
Real time pattern detection on NLS Pharmaceutics AG stock2025 Risk Factors & AI Enhanced Trade Execution Alerts - Newser
Signal strength of NLS Pharmaceutics AG Equity Warrant stock in tech scanners - Newser
How to use Fibonacci retracement on NLS Pharmaceutics AG Equity WarrantJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
When is the best time to exit NLS Pharmaceutics AG Equity WarrantJuly 2025 Breakouts & Expert-Curated Trade Recommendations - Newser
Tick level data insight on NLS Pharmaceutics AG volatilityFed Meeting & Proven Capital Preservation Methods - Newser
Short interest data insights for NLS Pharmaceutics AGQuarterly Profit Summary & Weekly High Return Forecasts - Newser
Price action breakdown for NLS Pharmaceutics AG Equity WarrantWeekly Volume Report & Expert Approved Momentum Trade Ideas - Newser
NLS Pharmaceutics (NASDAQ:NLSP) Trading Down 3.6% – What’s Next? - Defense World
NLS Pharmaceutics AG Equity Warrant stock momentum explainedJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - Newser
Price momentum metrics for NLS Pharmaceutics AG Equity Warrant explainedJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
Is NLS Pharmaceutics AG stock entering bullish territoryJuly 2025 Recap & AI Based Trade Execution Alerts - Newser
Visual analytics tools that track NLS Pharmaceutics AG Equity Warrant performanceTrade Analysis Summary & Safe Capital Growth Tips - Newser
NLS Pharmaceutics AG Equity Warrant’s volatility index tracking explainedJuly 2025 Setups & Fast Entry High Yield Tips - Newser
Watch for Trend Continuation in NLS Pharmaceutics AG Next Week2025 Market WrapUp & Safe Entry Zone Identification - beatles.ru
Using R and stats models for NLS Pharmaceutics AG forecastingWall Street Watch & Free Community Supported Trade Ideas - Newser
Using Ichimoku Cloud for NLS Pharmaceutics AG technicals2025 Institutional Moves & AI Powered Buy and Sell Recommendations - Newser
Is NLS Pharmaceutics AG Equity Warrant stock entering bullish territory2025 Year in Review & Real-Time Stock Price Movement Reports - Newser
Comparing NLS Pharmaceutics AG Equity Warrant in custom built stock radarsPortfolio Value Report & Real-Time Market Trend Scan - Newser
Building trade automation scripts for NLS Pharmaceutics AG Equity WarrantMarket Growth Summary & Breakout Confirmation Alerts - Newser
NLS Pharmaceutics Extends Merger Deadline with Kadimastem to October 31, 2025. - AInvest
NLS Pharmaceutics Extends Merger Agreement with Kadimastem - TipRanks
Detecting support and resistance levels for NLS Pharmaceutics AGInsider Selling & Technical Entry and Exit Tips - Newser
Is NLS Pharmaceutics AG Equity Warrant a candidate for recovery playTrade Exit Summary & Safe Capital Growth Tips - Newser
Published on: 2025-08-29 16:48:48 - Newser
Best data tools to analyze NLS Pharmaceutics AG stockTrade Analysis Report & Daily Volume Surge Signals - Newser
Nls Pharmaceutics Ltd (NLSP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):